title: Pharmacokinetics of ceftiofur in plasma and uterine secretions and tissues after subcutaneous postpartum administration in lactating dairy cows.
abstract: A study was conducted to measure concentrations of potentially active ceftiofur derivatives, in plasma, in uterine tissues (endometrium and caruncles) and in uterine secretions at different time points after a single subcutaneous administration of ceftiofur hydrochloride (Excenel RTU Sterile Suspension) at the dose of 1 mg/kg body weight in Holstein-Friesian dairy cows. The animals (n=4) were injected within 24 h of calving, after expulsion of the foetal membranes. Plasma, lochial fluid, caruncles and endometrium were collected before ceftiofur hydrochloride administration and at 1, 2, 4, 8, 12 and 24 h after treatment. For each cow the concentrations of ceftiofur in the biological matrices were quantified using an high-performance liquid chromatography (HPLC) assay. The limit of quantification of the method was 0.1 microg/mL for plasma and 0.1 microg/g for lochial fluid, caruncles and endometrium. The concentrations of potentially active ceftiofur derivatives detected in plasma reached a maximum of 2.85 +/- 1.11 microg/mL at 2 h and decreased to 0.64 +/- 0.14 microg/mL at 24 h after administration. In lochial fluid, these concentrations reached a maximum of 0.97 +/- 0.25 microg/g at 4 h and decreased to 0.22 +/- 0.21 microg/g at 24 h after administration. In endometrium, these concentrations reached a maximum of 2.23 +/- 0.82 microg/g at 4 h and decreased to 0.56 +/- 0.14 microg/g at 24 h following the injection, whereas these levels in caruncles were 0.96 +/- 0.45 and 0.60 +/- 0.39 microg/g obtained at 8 and 24 h, respectively. At the dose of 1 mg/kg body weight in healthy dairy cows, subcutaneous administration of ceftiofur (as ceftiofur hydrochloride) after parturition results in concentrations of ceftiofur derivatives in uterine tissues and in lochial fluid that exceed the reported minimal inhibitory concentrations (MICs) for the common pathogens (Escherichia coli, Fusobacterium necrophorum, Bacteroides spp., and Arcanobacterium pyogenes) associated with acute puerperal metritis.
authors.affiliation: Department of the Science of Food of Animal Origin, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 2, Utrecht, the Netherlands.
authors.forename: H
authors.initials: H
authors.lastname: Okker
authors.forename: E J
authors.initials: EJ
authors.lastname: Schmitt
authors.forename: P L A M
authors.initials: PL
authors.lastname: Vos
authors.forename: P
authors.initials: P
authors.lastname: Scherpenisse
authors.forename: A A
authors.initials: AA
authors.lastname: Bergwerff
authors.forename: F H
authors.initials: FH
authors.lastname: Jonker
mesh_terms: D000818:Animals; D019540:Area Under Curve; D001826:Body Fluids / Q000378:metabolism; D002417:Cattle / Q000378:metabolism*; D002511:Cephalosporins / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D005260:Female; D007279:Injections, Subcutaneous / Q000662:veterinary; D007774:Lactation; D049590:Postpartum Period; D014018:Tissue Distribution; D014599:Uterus / Q000378:metabolism*
chemical_list: D002511:Cephalosporins; C053503:ceftiofur